Our Opinion

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma, Inc., is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

The following press release specifically mentions the use of rodents in clinical trials:
http://ir.hemispherx.net/profiles/investor/ResLibraryView.asp?ResLibraryID=80748&GoTopage=6&Category=2178&BzID=2265&G=980

Company Description

Hemispherx Biopharma, Inc is a speciality pharmaceutical company headquartered in Philadelphia, Pennsylvania and engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders.